Fractalkine transgene induces T‐cell‐dependent antitumor immunity through chemoattraction and activation of dendritic cells
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Fractalkine (FK, also called neurotactin or CX3CL1) is a CX3C chemokine that can chemoattract T lymphocytes, monocytes and NK cells. In our study, we investigated the induction of antitumor response by FK gene transfer. FK gene‐modified 3LL lung carcinoma cells (3LL‐FK) could both secrete soluble form and express membrane‐bound form of FK. The tumor growth of 3LL‐FK was decreased. Vaccination with 3LL‐FK was effective in the induction of protective immunity and CTL. In vivo depletion analysis demonstrated that CD8+ T cells are the main participating cells of the antitumor response. Obvious infiltrations of CD8+ T cells, CD4+ T cells and dendritic cells (DC) were observed in the tumor sites, suggesting that 3LL‐FK might induce antitumor immunity through chemoattraction and activation of T cells and DC. Then we investigated the chemoattraction and activation of DC by 3LL‐FK. Chemotaxis assay showed that the supernatants of 3LL‐FK could chemoattract immature DC, which were found to express FK receptor CX3CR1, and the immature DC could obviously adhere to 3LL‐FK. Adherence of DC to 3LL‐FK resulted in phenotypic maturation and upregulated IL‐12 secretion of DC, and more strong stimulation of allogeneic T‐cell proliferation by DC. The increased production of IL‐2 and IFNγ in 3LL‐FK tumor tissue was also observed. Our data suggested that FK gene transfer to tumor cells could induce T‐cell‐dependent antitumor immunity through chemoattraction and activation of DC. © 2002 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new class of membrane-bound chemokine with a CX3C motif
Bazan, J. F., Bacon, K. B., Hardiman, G., Wang, W., Soo, K., Rossi, D., Greaves, D. R., Zlotnik, A., & Schall, T. J. (1997) · Nature · doi:10.1038/385640a0 · Cited by 2,013
Cited by
Tissue-specific Role of CX3CR1 Expressing Immune Cells and Their Relationships with Human Disease
Lee, M., Lee, Y., Song, J., Lee, J., & Chang, S.-Y. (2018) · Immune Network · doi:10.4110/in.2018.18.e5 · Cited by 260
“CX3CL1 induces T-cell-dependent antitumor immunity through chemoattraction and activation of DCs (97).”
BackgroundInfluentialYan, Y., Cao, S., Liu, X., Harrington, S. M., Bindeman, W. E., Adjei, A. A., Jang, J. S., Jen, J., Li, Y., Chanana, P., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.97828 · Cited by 169
Ungaro, R., Fukata, M., Hsu, D., Hernandez, Y., Breglio, K., Chen, A., Xu, R., Sotolongo, J., Espana, C., Zaias, J., et al. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90496.2008 · Cited by 159
D'Haese, J. G., Demir, I. E., Friess, H., & Ceyhan, G. O. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903540265 · Cited by 116
“Vaccination of mice with fractalkine-transfected Lewis lung carcinoma cells induces a potent anti-tumor response due to the strong chemoattraction of natural killer cells into the tumor sites (Table 1) [62,63].”
BackgroundLavergne, E., Combadière, C., Iga, M., Boissonnas, A., Bonduelle, O., Maho, M., Debré, P., & Combadiere, B. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.3755 · Cited by 89
“We showed that CX3CL1-expressing EL-4 and EG-7 cells reduced tumor growth by increasing NK cell recruitment, but we observed no increase in T cell recruitment.”
BackgroundInfluential
Metadata
- Authors
- Guo, J., Zhang, M., Wang, B., Yuan, Z., Guo, Z., Chen, T., Yu, Y., Qin, Z., & Cao, X.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2002-11-26
- Volume
- 103
- Issue
- 2
- Pages
- 212-220
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2095484603
- Cited by
- 79
- References
- 1
- FWCI
- 1.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.